Disease | glioma |
Phenotype | C0025149|medulloblastoma |
Sentences | 2 |
PubMedID- 23418531 | A. tumor cdna panel (biochain institute, usa): 1 – brain medulloblastoma, with glioma, 2 – lung squamous cell carcinoma, 3 – kidney granular cell carcinoma, 4 – kidney clear cell carcinoma, 5 – liver cholangiocellular carcinoma, 6 – hepatocellular carcinoma, 7 – gallbladder adenocarcinoma, 8 – esophagus squamous cell carcinoma, 9 – stomach signet ring cell carcinoma, 10 – small intestine adenocarcinoma, 11 – colon papillary adenocarcinoma, 12 – rectum adenocarcinoma, 13 – breast fibroadenoma, 14 – ovary serous cystoadenocarcinoma, 15 – fallopian tube medullary carcinoma, 16 – uterus adenocarcinoma, 17 – ureter papillary transitional cell carcinoma, 18 – bladder transitional cell carcinoma, 19 – testis seminoma, 20 – prostate adenocarcinoma, 21 – malignant melanoma, 22 – skeletal muscle malignancy fibrous histocytoma, 23 – adrenal pheochromocytoma, 24 – non-hodgkin's lymphoma, 25 – thyroid papillary adenocarcinoma, 26 – parotid mixed tumor, 27 – pancreas adenocarcinoma, 28 – thymus seminoma, 29 – spleen serous adenocarcinoma, 30 – hodgkin's lymphoma, 31 – t cell hodgkin's lymphoma, 32 – malignant lymphoma. |
PubMedID- 25125325 | Mean prf values were significantly larger for medulloblastoma compared with glioma, with a difference in the means of 0.0147 ppm (p < 0.05), while the mean prf for glioma was significantly lower than for the healthy cohort, with a difference in the means of 0.0061 ppm (p < 0.05). |
Page: 1